Curcumin-Based Nanocarriers for Alzheimer’s Disease: A Promising Therapeutic Avenue
Globally, over 55 million people are affected by Alzheimer’s disease (AD), a number that is increasing rapidly and projected to triple by 2050. AD is a type of neurodegenerative disorder for which there is no curative treatment. The accumulation of amyloid-β (Aβ) plaques and the formation of neurofibrillary tangles are...